☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Feb 2017
Amgen Launches Amgevita (adalimumab- biosimilar) in EU to Treat Inflammatory Diseases post EMA Approval in Feb 2017
October 16, 2018
Load more...
Back to Home